Polycythemia vera: diagnosis, clinical course, and current management

Abstract excerpt

Very important developments related to polycythemia vera (PV) have occurred during the last two decades. The discovery of Janus kinase (JAK) 2 mutations has changed both the diagnosis and clinical management of PV. Currently JAK2 molecular testing is essential in the diagnostic work-up and JAK2 mutation positivity is a major diagnostic criterion. The discovery of JAK2 mutations suggested that abnormal...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease Management
• Share to Disease Progression
• Share to JAK1 gene